S2k Guideline for the Treatment of Hidradenitis Suppurativa / Acne Inversa – Short Version

    May 2024 in “ JDDG Journal der Deutschen Dermatologischen Gesellschaft ”
    Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz … Viktor A. Zouboulis
    Studysummary This guideline outlines therapies for hidradenitis suppurativa/acne inversa, noting that oral tetracyclines, clindamycin, and surgical options are important for treatment, with adalimumab, secukinumab, and bimekizumab also approved.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis Pharmaceutics · 2021
    2. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients Frontiers in Medicine · 2021
    3. What Causes Hidradenitis Suppurativa?—15 Years After Experimental Dermatology · 2020
    4. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data American Journal of Clinical Dermatology · 2019